Loss of heterozygosity and p53 expression in Pterygium

被引:55
|
作者
Reisman, D [1 ]
McFadden, JW
Lu, G
机构
[1] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA
[2] City Hope Natl Med Ctr, Div Pathol, Duarte, CA 91010 USA
关键词
tumor suppressor; gene expression; fluorescent in situ hybridization;
D O I
10.1016/j.canlet.2003.10.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
While the pathogenesis of pterygium is still not well understood, environmental factors such at UV light, appear to play an important role in its development. UV radiation can cause mutations in genes such as the p53 tumor suppressor gene, that when inactivated through mutation and loss of heterozygosity can lead to cell proliferation and genomic instability. However, aside from mutations in the gene, other mechanisms have been identified that can lead to loss of p53 function. These include the interaction of the p53 protein with cellular or viral gene products that lead to the inactivation of p53 or to its rapid degradation as well as the silencing of transcription of the p53 gene through the aberrant expression of factors that control p53 expression. We have analyzed the status and expression of the p53 gene in epithelial cells derived from pterygium and have demonstrated that the p53 gene has undergone a monoallelic deletion. Assays for both p53 protein and mRNA revealed that the remaining allele in these cells is not expressed at detectable levels. Furthermore, the remaining allele, by DNA sequence analysis appears to remain wild type. The mechanism of silencing the p53 gene and the loss of p53 expression in these cells is currently under investigation. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:77 / 83
页数:7
相关论文
共 50 条
  • [21] Survivin and p53 expression in primary and recurrent pterygium in Chinese patients
    Zhang, Li-Wei
    Chen, Bai-Hua
    Xi, Xing-Hua
    Han, Qian-Qian
    Tang, Luo-Sheng
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (04) : 388 - 392
  • [22] P53 TUMOR-SUPPRESSOR GENE-EXPRESSION IN PTERYGIUM
    HU, FR
    WANG, IJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S1027 - S1027
  • [23] Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients
    Cho, S
    Hahm, JH
    Hong, YS
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) : 841 - 848
  • [25] Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors
    Rohini, K.
    Mathivanan, J.
    Prabhu, P. D. Antony Herold
    Subbakrishna, D. K.
    Gope, M. L.
    Chandramouli, B. A.
    Sampath, S.
    Anandh, B.
    Gope, R.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2007, 300 (1-2) : 101 - 111
  • [26] p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
    Evguenia M Alexandrova
    Safia A Mirza
    Sulan Xu
    Ramona Schulz-Heddergott
    Natalia D Marchenko
    Ute M Moll
    Cell Death & Disease, 2017, 8 : e2661 - e2661
  • [27] p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
    Alexandrova, Evguenia M.
    Mirza, Safia A.
    Xu, Sulan
    Schulz-Heddergott, Ramona
    Marchenko, Natalia D.
    Moll, Ute M.
    CELL DEATH & DISEASE, 2017, 8 : e2661 - e2661
  • [28] Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors
    K. Rohini
    J. Mathivanan
    P. D. Antony Herold Prabhu
    D. K. Subbakrishna
    M. L. Gope
    B. A. Chandramouli
    S. Sampath
    B. Anandh
    R. Gope
    Molecular and Cellular Biochemistry, 2007, 300 : 101 - 111
  • [29] Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas
    Schiebe, M
    Ohneseit, P
    Hoffmann, W
    Meyermann, R
    Rodemann, HP
    Bamberg, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (05) : 325 - 328
  • [30] Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas
    Martina Schiebe
    Petra Ohneseit
    Wolfgang Hoffmann
    Richard Meyermann
    Hans-Peter Rodemann
    Michael Bamberg
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 325 - 328